These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 31403685)
81. Molecular analysis of PinX1 in medulloblastomas. Chang Q; Pang JC; Li J; Hu L; Kong X; Ng HK Int J Cancer; 2004 Mar; 109(2):309-14. PubMed ID: 14750185 [TBL] [Abstract][Full Text] [Related]
82. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients. Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568 [TBL] [Abstract][Full Text] [Related]
83. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Grammel D; Warmuth-Metz M; von Bueren AO; Kool M; Pietsch T; Kretzschmar HA; Rowitch DH; Rutkowski S; Pfister SM; Schüller U Acta Neuropathol; 2012 Apr; 123(4):601-14. PubMed ID: 22349907 [TBL] [Abstract][Full Text] [Related]
84. Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma. Vortmeyer AO; Stavrou T; Selby D; Li G; Weil RJ; Park WS; Moon YW; Chandra R; Goldstein AM; Zhuang Z Cancer; 1999 Jun; 85(12):2662-7. PubMed ID: 10375116 [TBL] [Abstract][Full Text] [Related]
86. Rethinking medulloblastoma from a targeted therapeutics perspective. Hashimoto Y; Penas-Prado M; Zhou S; Wei J; Khatua S; Hodges TR; Sanai N; Xiu J; Gatalica Z; Kim L; Kesari S; Rao G; Spetzler D; Heimberger A J Neurooncol; 2018 Sep; 139(3):713-720. PubMed ID: 29869738 [TBL] [Abstract][Full Text] [Related]
87. Medulloblastomas with favorable versus unfavorable histology: how many small blue cell tumor types are there in the brain? Perry A Adv Anat Pathol; 2002 Nov; 9(6):345-50. PubMed ID: 12409643 [TBL] [Abstract][Full Text] [Related]
88. Ploidy and proliferative index in medulloblastoma: useful prognostic factors? Tait DM; Eeles RA; Carter R; Ashley S; Ormerod MG Eur J Cancer; 1993; 29A(10):1383-7. PubMed ID: 8398263 [TBL] [Abstract][Full Text] [Related]
89. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. Cho YJ; Tsherniak A; Tamayo P; Santagata S; Ligon A; Greulich H; Berhoukim R; Amani V; Goumnerova L; Eberhart CG; Lau CC; Olson JM; Gilbertson RJ; Gajjar A; Delattre O; Kool M; Ligon K; Meyerson M; Mesirov JP; Pomeroy SL J Clin Oncol; 2011 Apr; 29(11):1424-30. PubMed ID: 21098324 [TBL] [Abstract][Full Text] [Related]
90. Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study. Moreno DA; da Silva LS; Zanon MF; Bonatelli M; de Paula FE; de Medeiros Matsushita M; Teixeira GR; Santana IVV; Saggioro F; Neder L; Stavale JN; Malheiros SMF; Lima M; Hajj GNM; Garcia-Rivello H; Christiansen S; Nunes S; da Costa MJG; Soares MJ; Pinheiro J; Junior CA; Mançano BM; Reis RM J Neurooncol; 2022 Mar; 157(1):27-35. PubMed ID: 35166989 [TBL] [Abstract][Full Text] [Related]
91. Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors. Uchida E; Sasaki A; Shirahata M; Suzuki T; Adachi JI; Mishima K; Yasuda M; Fujimaki T; Ichimura K; Nishikawa R Brain Tumor Pathol; 2022 Jul; 39(3):130-138. PubMed ID: 35000018 [TBL] [Abstract][Full Text] [Related]
92. Medulloblastomas in adolescents and adults - Can the pediatric experience be extrapolated? Frappaz D; Faure-Conter C; Bonneville Levard A; Barritault M; Meyronet D; Sunyach MP Neurochirurgie; 2021 Feb; 67(1):76-82. PubMed ID: 30554773 [TBL] [Abstract][Full Text] [Related]
96. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth. Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539 [TBL] [Abstract][Full Text] [Related]
97. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413 [TBL] [Abstract][Full Text] [Related]
98. Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer. Bühren J; Christoph AH; Buslei R; Albrecht S; Wiestler OD; Pietsch T J Neuropathol Exp Neurol; 2000 Mar; 59(3):229-40. PubMed ID: 10744061 [TBL] [Abstract][Full Text] [Related]
99. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123 [TBL] [Abstract][Full Text] [Related]
100. OTX1 and OTX2 Genes in Medulloblastoma. Figueira Muoio VM; Uno M; Oba-Shinjo S; da Silva R; Araújo Pereira BJ; Clara C; Matushita H; Marie SNK World Neurosurg; 2019 Jul; 127():e58-e64. PubMed ID: 30797919 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]